Interim 4'-[methyl-11C]-thiothymidine PET for predicting the chemoradiotherapeutic response in head and neck squamous cell carcinoma: comparison with [18F]FDG PET.
Katsuya MitamuraTakashi NorikaneYuka YamamotoKengo FujimotoYasukage TakamiHiroshi HoshikawaJun ToyoharaYoshihiro NishiyamaPublished in: EJNMMI research (2021)
These preliminary results suggest that interim [11C]4DST PET might be useful for predicting the chemoradiotherapeutic response in patients with HNSCC, in comparison with [18F]FDG PET.